We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Humedics Starts LiMAx Phase III Trial on Liver Function Analysis for Severe Liver Surgery

News   Mar 04, 2013

 
Humedics Starts LiMAx Phase III Trial on Liver Function Analysis for Severe Liver Surgery
 
 
Advertisement
 

RELATED ARTICLES

New Test Can Target and Capture Most Lethal Cells in Fatal Brain Cancer

News

A laboratory test developed by a research team led by Johns Hopkins University bioengineers can accurately pinpoint, capture and analyze the deadliest cells in the most common and aggressive brain cancer in adults.

READ MORE

Glutathione Precursor Improves Conditions Associated With Premature Aging in HIV Patients

News

An open-label clinical trial found that a glutathione precursor, GlyNAC, reverses premature aging in people with HIV.

READ MORE

NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials

News

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapeutics or investigational drugs in late clinical development show promise against COVID-19 and warrant advancement into larger clinical trials.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE